Tilray Brands (TSE:TLRY) Trading 13.3% Higher - Still a Buy?

Key Points

• Tilray Brands, Inc. shares increased by 13.3% on Monday, reaching a maximum price of C$1.11 after closing at C$0.90.
• The company has a debt-to-equity ratio of 10.76 and a market capitalization of C$818.35 million, indicating potential financial concerns.
• Tilray mainly focuses on the Canadian cannabis market and exports medical cannabis internationally, in addition to offering CBD products and beer in the U.S.

Tilray Brands, Inc. (TSE:TLRY - )'s share price was up 13.3% on Monday . The company traded as high as C$1.11 and last traded at C$1.02. Approximately 3,900,548 shares traded hands during mid-day trading, an increase of 132% from the average daily volume of 1,684,094 shares. The stock had previously closed at C$0.90.

Tilray Brands Stock Performance

The company has a debt-to-equity ratio of 10.76, a current ratio of 2.54 and a quick ratio of 2.16. The stock has a market capitalization of C$818.35 million, a P/E ratio of -3.07 and a beta of 2.19. The company has a fifty day moving average of C$0.71 and a two-hundred day moving average of C$0.85.

Tilray Brands Company Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.